Cannabidiol (CBD)The most prominent cannabinoid accounting for up to 40% of the plant’s extract. Extensive research has displayed the powerful anti oxidative properties of CBD which is believed to have a broadrange of medical applications including helping with anxiety, inflammation, pain, seizures, and potentially cancer.
Cannabinol (CBN)A minor cannabinoid that is unique to the cannabis plant and is more prevalent in older cannabis. While the study of CBN has been limited, the most common potential benefits of the non-intoxicating compound are antibacterial and neuroprotectant properties, as well as appetite stimulation. CBN may also behelpful for those suffering from glaucoma by reducing intraocular pressure. CBN also acts as an anti-inflammatory.
Cannabichromene (CBC)Discovered over 50 years ago, CBC is considered one of the ‘big six’ cannabinoids prominent in medical research as its benefits are extremely promising. CBC is non-intoxicating andunlike other cannabinoids, does not bind well with CB1 receptors. Instead, it binds with other receptors in the body,such as the vanilloid receptor which is linked to pain perception. The potential benefits of CBC have far-reaching implications for medical conditions including cancer, pain and inflammation, depression, and has shown promise forincreasing brain function.
Cannabigerol (CBG)A lesser-known cannabinoid that is more present when the Hemp plant is bud-ding. It has been found to act on very specific physiological systems and problems, and results for medicinal use are promising. Of particular note, CBG is thought to be particularly effective in treating glaucoma and inflammatory bowel disease. It is also showing great promise as a cancer fighter by blocking receptors that cause cancer cellgrowth, thereby slowing cancer growth.
Cannabidivarin (CBDV)Similar in structure to CBD, CBDV is non-intoxicating and has been at thefocal point for cannabinoid research due to its effect on seizures. CBDV has shown to effect the neurochemicalpathway of the capsaicin receptors involved in both the onset as well as the progression of several types of epi- lepsy. Studies also suggest that CBDV has potential in helping issues associated with Rett syndrome, Duchenne muscular dystrophy, and autism spectrum disorder, to name a few.
Cannabigerovarin (CBGV )Like other cannabinoids previously mentioned, CBGV is being heavily researched for its ability to positively impact cancer treatment by shrinking cancer cells and preventing metastasis.CBGV helps to boost the metabolism of CBD, so CBD oils where CBGV is present will have an increased effectiveness.
Tetrahydrocannabivarin (THCV)Similar to THC in structure, THCV shows medicinal prom- ise as it acts as an appetite suppressant, blood sugar regulation and bone cell growth agent. THCV has also beenshown to help tremors and motor control issues associated with Alzheimer’s disease. Research is still ongoing.
Delta 9 Tetrahydrocannabinol (THC)The cannabinoid most widely known for its abundance and euphoric attributes.